Availability of new non-oncology orphan drugs in Europe 2023, by country
This statistic displays the number of non-oncology orphan medicines approved by the European Medicines Agency (EMA) between 2018 and 2021 which were available to patients in selected European countries as of January 5, 2023. According to the data, Germany had 38 of the 44 approved non-oncology orphan medicines available to patients, the highest amount in Europe.